Santa Farma, which has been deemed worthy of many international awards with the awareness projects it has signed so far, has added a new one to this success. The 'Leave a Yellow Note to Life' project, unconditionally supported by Santa Farma, was awarded the Golden Award in the medical website category at the Ava Digital Awards advertising and marketing competition.
by signing the project will raise awareness of 'healthy health service' and the path of Turkey's 77 years of established local Santa Farma pharmaceutical company, he has added a new round of international success.
With the unconditional support of Santa Farma and the Association for Combating Viral Hepatitis, the 'Leave a Yellow Note to Life' project, which was initiated in 2018 to raise awareness on Hepatitis B disease, was awarded the Gold Award in the medical website category at the Ava Digital Awards advertising and marketing competition. .
'Leave a Yellow Note to Life' awareness project, previously; The Golden Spider was awarded at the Felis and MarCom Awards.
It has been organized for about 27 years
AVA Awards have been organized since 1994 by the Association of Marketing Communication Professionals (AMCP), one of the world's most established and respected marketing and communication platforms. USA-based AVA Awards awards the most prestigious works in digital marketing from over 200.000 participants worldwide each year, with a jury appointed by AMCP.
4 million people reached
Approximately four million people were reached in the first four months with the 'Leave a Yellow Note to Life' project, which was implemented in order to increase the awareness of Hepatitis B in the society and to ensure that more people get tested and take precautions. Under the project, Turkey's most-watched channel street interviews done in cooperation with Yellow Microphone beloved player Hayreddin project sözcüStreet interviews were carried out with greatness. People in the viral video "for 1.8 million people in Turkey 'B' What does that mean?" People were informed about Hepatitis B.
Be the first to comment